Diane C. Young - 07 Jun 2024 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role: SVP, CHIEF MEDICAL OFFICER
Signature: /s/ Sam Martin, attorney-in-fact for Diane C. Young
Issuer symbol: CLDX
Transactions as of: 07 Jun 2024
Net transactions value: -$1,586,844
Form type: 4
Filing time: 11 Jun 2024, 16:01:54 UTC
Previous filing: 20 Jun 2023
Next filing: 13 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLDX	Common Stock	Sale	$1,586,844	-45,000	-96%	$35.26	2,115	07 Jun 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.67 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.67 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.